98229306 - RNGD

Information

• Trademark
• 98229306

• Source

• Serial Number

  98229306

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 18, 2023
  8 months ago

• Transaction Date

  May 02, 2024
  2 months ago

• Status Date

  May 02, 2024
  2 months ago

• Location Date

  May 02, 2024
  2 months ago

• Status Code

  641

• Current Location

  TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  SEGAL, MOLLY DANIELA

• Attorney Docket Number

  131399-0003

  Attorney Name

  Kristin H. Altoff

  Law Office Assigned Location Code

  L50

• Owners

  • ReNAgade Therapeutics Management Inc.

Case File Statements

• GS0051: Pharmaceutical and biological preparations and substances, namely, preparations; Pharmaceutical preparations, namely, nucleic acid therapeutics and delivery vehicles being RNA and DNA therapeutics for scientific, research, medical, or pharmaceutical use; Pharmaceutical preparations, namely, nucleic acid therapeutics and delivery vehicles being RNA and DNA therapeutics which constitute and encode one or more components utilized in genome editing, gene editing, genome engineering, recombineering, gene modulation, transcriptional regulation, transcriptional modulation, gene therapy or cell therapy, for scientific, research, medical, or pharmaceutical use; Human and veterinarian vaccine preparations; Vaccines; Anti-epileptic pharmaceutical preparations; Medical preparations for the treatment of cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, reproductive disorders, infectious diseases for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations in the nature nucleic acid delivery agents; Chemical and biological reagents for medical or veterinary purposes, namely, for nucleic acid therapy; Biological preparations for medical, pharmaceutical or veterinary purposes, namely, for use in connection with nucleic acid therapy; Pharmaceutical and veterinary preparations, namely, nano particles to improve delivery of plasmid DNA and messenger RNA molecules; nano particles for the delivery of pharmaceutical or veterinary agents and preparations; nano particles for drug delivery; engineered nucleic acids for delivery of therapeutic DNA or mRNA sequences to cells, all for clinical use, medical use, clinical laboratory use, and medical laboratory use; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Enzymes and nucleic acid sequences for medical use, namely, for the modification of cells and RNA and DNA; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and RNA and DNA editing; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene, genome, and cellular editing, modulation, and modification for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; Enzymes, nucleic acid molecules, and compounds/agents for modifying small RNAs with targeting agents for medical use, namely, use of the modified small RNAs in the gene editing industry; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation; Drug delivery agents in the form of pharmaceutical preparations, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds directed to lipid nanoparticles for the purpose of delivering pharmaceutical preparations to specific target tissue sites; drug delivery agents in the form of pharmaceutical preparations, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds and agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations; drug delivery agents consisting of pharmaceutical preparations and therapeutic agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations for RNA, gene therapy and mRNA regulation; drug delivery agents consisting of pharmaceutical and biological preparations for medical use that facilitate the release and delivery of a wide variety of pharmaceutical preparations for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; drug delivery agents consisting of pharmaceutical preparations that facilitate the release and delivery of a wide variety of pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation; pharmaceutical preparations, namely, vaccines; Pharmaceutical preparations, lipids, lipid nanoparticles, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds/agents for medical use
• GS0011: Biochemical preparations for scientific purposes; Biochemicals for use in the manufacture of RNA therapeutics and DNA therapeutics; Biochemicals for use in the manufacture of pharmaceuticals for treating cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; Diagnostic preparations for scientific, research, clinical and medical laboratory use; chemicals for use in pharmaceutical, biotherapeutics, biosimilars and therapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory use; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Nucleic acid for laboratory use; Protein in raw material form for scientific and medical research; Reagents for scientific and research use and for testing the sterility of pharmaceuticals; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; Antioxidants for use in the manufacture of pharmaceuticals; Biochemicals for in vitro, in vivo, or ex vivo scientific use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Catalysts for chemical and biochemical processes; Cells for scientific, laboratory or medical research; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the biochemical and chemical industry; Enzymes for use in protein hydrolysis; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Plant extracts for use in the manufacture of pharmaceuticals; Protein arrays and nucleotide arrays for scientific and medical research; chemical reagents for scientific or research use, namely, used in gene or nucleic acid delivery systems; nano-particles, namely, those composed predominantly of polymers, used in the manufacture of pharmaceuticals; genome editing reagents for research purposes; genome engineering reagents for scientific and research purposes; genome editing and amplification reagents for scientific and research purposes; Chemical and biological agents for scientific and research use, namely, for manipulating or modifying RNA and DNA; enzymes for scientific and research purposes; enzyme preparations for use in the gene editing industry; Nucleic acid sequences for other than medical and veterinary purposes; Chemical and biological agents for scientific and research use, namely, for the modification of small RNAs with targeting agents and for regulating expression and/or levels of mRNA with the modified RNAs; enzyme preparations for use in modifying small RNAs and for use of modified small RNAs in the gene editing industry; Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acids and modified nucleic acids, including short RNAs and messenger RNAs; nucleic acid sequences for scientific purposes, research purposes, and laboratory purposes other than medical and veterinary purposes
• GS0421: Pharmaceutical research and development; Scientific research and development; Vaccine research and development; Research and development in the pharmaceutical and biotechnology fields and in the fields of vaccines, medicines and antibodies; Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; design, engineering and scientific research in the fields of genome editing, gene editing, genome engineering, recombineering, gene modulation, transcriptional regulation, transcriptional modulation, gene therapy or cell therapy, in the field of pharmaceutical and biological preparations and substances, including nucleic acid therapeutics and delivery vehicles; Testing of pharmaceuticals and biotherapies; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; Medical and scientific research in the field of cancer treatment and diagnosis; Scientific research for medical purposes in the field of nucleic acids, inhibitory nucleic acids, protein-encoding nucleic acids and polypeptide-encoding nucleic acids; Research in the fields of pharmaceutical and biological therapeutic preparations, namely, nucleic acid delivery systems; conducting clinical trials for others; Research and development in the field of technology and engineering for the modification of RNA and DNA and gene editing technology; development of new technology for others for enabling the engineering and modification of RNA and DNA, namely, developing molecular and cellular biology reagents, techniques, and assays for the modification of cells and RNA and DNA; Research and development in the field of technology and engineering RNAs with targeting agents for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of RNA with targeting agents, namely, developing molecular and cellular biology reagents, techniques, and assays for use in the gene editing industry; Research and development in the field of technology and engineering, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, drug delivery agents and RNAs for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, RNAs, namely, developing molecular and cellular biology reagents, techniques, drug delivery agents and assays for use in pharmaceutical and biomedical industry

Case File Event Statements

• 10/21/2023 - 8 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/24/2023 - 8 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/26/2024 - 2 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 5/2/2024 - 2 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/2/2024 - 2 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/2/2024 - 2 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT